Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.

PrecisionLife and Ovation.io on Wednesday said they inked an agreement to launch a consumer-facing genetic test for identifying patients' likelihood of responding to GLP-1 receptor agonists. The ...

He suggested that she ask her doctor about trying a GLP-1 drug off-label, a common practice in which a medication is ...

AUSTIN, Texas, April 9, 2026 /PRNewswire/ -- Choose Health, an at-home blood testing company specializing in liver and metabolic health, today announced the launch of the GLP-1 Health Monitoring ...

BENTONVILLE, Ark. (KNWA/KFTA) — GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson Diagnostics. The companies say the GLP-1 Test Panel ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...

New research shows genetic differences can reduce GLP-1 drug effectiveness, meaning some patients may not see expected ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...